Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy responseShengshan Xu, Zhuming Lu, Youbin Zheng et al.|BMC Cancer|2024Cited by 50
The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer AnalysisShengshan Xu, Hejie Liu, Youbin Zheng et al.|Journal of Inflammation Research|2025Cited by 48
Multi‑omics identification of a signature based on malignant cell-associated ligand–receptor genes for lung adenocarcinomaShengshan Xu, Zhuming Lu, Xiguang Chen et al.|BMC Cancer|2024Cited by 36
A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast CancerShengshan Xu, Yihang Pan, Yuchen Liu et al.|Frontiers in Genetics|2022Cited by 32
Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2Shengshan Xu, Yuchen Liu, Xiguang Chen et al.|Frontiers in Immunology|2023Cited by 26